The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia

Notwithstanding the introduction of Tyrosine Kinase Inhibitors (TKIs) revolutionized the outcome of Chronic Myeloid Leukemia (CML), one third of patients still suspends treatment for failure response. Recent research demonstrated that several BCR/ABL1-independent mechanisms can sustain resistance, b...

Descripción completa

Detalles Bibliográficos
Autores principales: Grassi, Susanna, Palumbo, Sara, Mariotti, Veronica, Liberati, Diego, Guerrini, Francesca, Ciabatti, Elena, Salehzadeh, Serena, Baratè, Claudia, Balducci, Serena, Ricci, Federica, Buda, Gabriele, Iovino, Lorenzo, Mazziotta, Francesco, Ghio, Francesco, Ercolano, Giacomo, Di Paolo, Antonello, Cecchettini, Antonella, Baldini, Chiara, Mattii, Letizia, Pellegrini, Silvia, Petrini, Mario, Galimberti, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601352/
https://www.ncbi.nlm.nih.gov/pubmed/31293972
http://dx.doi.org/10.3389/fonc.2019.00532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601352/
https://www.ncbi.nlm.nih.gov/pubmed/31293972
http://dx.doi.org/10.3389/fonc.2019.00532

Ejemplares similares